Frontiers Article Alert

Monday, 27 January 2014

 

Frontiers is pleased to announce a number of exciting new articles in the field of Oncology.

 

Frontiers in Oncology, Section “Cancer Endocrinology”

Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast Cancer
David M. Marcus, Jeffrey M. Switchenko, Roshan Prabhu, Ruth O'Regan, Amelia Zelnak, Carolina Fasola, Donna Mister, and Mylin A. Torres

Frontiers in Oncology, Section “Cancer Epidemiology and Prevention”

Genetic Variation in the Extended Major Histocompatibility Complex and Susceptibility to Childhood Acute Lymphoblastic Leukemia: A Review of the Evidence
Kevin Y Urayama, Pamela D Thompson, Graham Malcolm Taylor, Elizabeth A Trachtenberg, and Anand P Chokkalingam
Concordant Oral-Genital HPV Infection in South Africa Couples: Evidence for Transmission
Samantha Lee Vogt, Patti E Gravitt, Neil A Martinson, Jennifer Hoffmann, and Gypsyamber DSouza
Coverage of Cervical Cancer Screening in Catalonia for the Period 2008–2011 among Immigrants and Spanish-Born Women
Vanesa Rodriguez-Sales, Esther Roura, Raquel Ibañez, Mercè Peris, F. Xavier Bosch, and Silvia De Sanjose
Comparison of Antibody Responses to Human Papillomavirus Vaccination as Measured by Three Assays
Hilary Ann Robbins, Troy J Kemp, Carolina Porras, Ana Cecilia Rodriguez, Mark Schiffman, Sholom Wacholder, Paula Gonzalez, John Schiller, Douglas Lowy, Sylviane Poncelet, Mark Esser, Katie Matys, Allan Hildesheim, Ligia A Pinto, Rolando Herrero, and Mahboobeh Safaeian

Frontiers in Oncology, Section “Cancer Genetics”

Skin Tumors Rb(eing) Uncovered
CLOTILDE COSTA, Jesus M Paramio, and MIRENTXU SANTOS
Melanoma Genetics/Genomics
Mike Eccles
Genetically Modified T Cells to Target Glioblastoma
Simone Krebs, Tania G Rodríguez-Cruz, Christopher DeRenzo, and Stephen Gottschalk
What Factors Impact upon a Woman’s Decision to Undertake Genetic Cancer Testing?
Julie Anne Quinlivan, Zain Battikhi, and Rodney Waldemar Petersen
Evidence That GRIN2A Mutations in Melanoma Correlate with Decreased Survival
Stacey Ann N D'mello, Jack U Flanagan, Taryn N Green, Euphemia Y Leung, Marjan E Askarian-Amiri, Wayne R Joseph, Michael R McCrystal, Richard J Isaacs, James H F Shaw, Christopher E Furneaux, Matthew J During, Graeme J FInlay, Bruce C Baguley, and Maggie Lucy Kalev-Zylinska

Frontiers in Oncology, Section “Cancer Molecular Targets and Therapeutics”

The Unpluggable in Pursuit of the Undruggable: Tackling the Dark Matter of the Cancer Therapeutics Universe
Richard J. Epstein
Biological Effects of Green Tea Capsule Supplementation in Pre-Surgery Postmenopausal Breast Cancer Patients
Steven S Yu, Darcy V Spicer, Debra Hawes, Chiu-Chen Tseng, Chung S Yang, Malcolm C Pike, and Anna H Wu
Structural Implications for Selective Targeting of PARPs
Jamin D. Steffen, Jonathan R. Brody, Roger S. Armen, and John Matteson Pascal

Frontiers in Oncology, Section “Gastrointestinal Cancers”

Functions and Regulation of the PTEN Gene in Colorectal Cancer
Francesca Molinari and Milo Frattini

Frontiers in Oncology, Section “Genitourinary Oncology”

Age and Racial Differences among PSA-Detected (AJCC Stage T1cN0M0) Prostate Cancer in the U.S.: A Population-Based Study of 70,345 Men
Hong Zhang, Edward M Messing, Lois B Travis, Ollivier Hyrien, Rui Chen, Michael T Milano, and Yuhchyau Chen
Effects of RANKL-Targeted Therapy in Immunity and Cancer
Michael L Cheng and Lawrence Fong

Frontiers in Oncology, Section “Molecular and Cellular Oncology”

Multi-Layered Cancer Chromosomal Instability Phenotype
Anna V Roschke and Ester Rozenblum
New Mitotic Regulators Released from Chromatin
Hideki Yokoyama and Oliver Gruss
The Role of Syndecan-1 in Cellular Signaling and its Effects on Heparan Sulfate Biosynthesis in Mesenchymal Tumors
Tünde Szatmári and Katalin Dobra
Glycosylation of Glycolipids in Cancer: Basis for Development of Novel Therapeutic Approaches
Jose Luis Daniotti, Aldo Alejandro Vilcaes, Vanina Torres Demichelis, Fernando Miguel Ruggiero, and Macarena Rodriguez-Walker

Frontiers in Oncology, Section “Molecular and Cellular Oncology” (Continued)

Next-Generation Sequencing of Disseminated Tumor Cells
Elen Kristine Møller, Parveen Kumar, Thierry Voet, April Peterson, Peter Van Loo, Randi R. Mathiesen, Renathe Fjelldal, Jason Grundstad, Elin Borgen, Lars O. Baumbusch, Bjørn Naume, Anne-Lise Børresen-Dale, Kevin P. White, Silje Nord, and Vessela N. Kristensen
Serglycin: At the Crossroad of Inflammation and Malignancy
Angeliki Korpetinou, Spyros S Skandalis, Vassiliki T Labropoulou, Gianna Smirlaki, Argyrios Noulas, Nikos K. Karamanos, and ACHILLEAS D. THEOCHARIS
Post-Synthetic Regulation of HS Structure: The Yin and Yang of the Sulfs in Cancer
Romain R Vives, Amal Seffouh, and Hugues Lortat-Jacob
Radiotherapy and the Tumor Stroma: The Importance of Dose and Fractionation
Turid Hellevik and Inigo Martinez-Zubiaurre

Frontiers in Oncology, Section “Pharmacology of Anti-Cancer Drugs”

Drug-Diagnostics Co-Development in Oncology
Richard Simon
Biomarker-Guided Repurposing of Chemotherapeutic Drugs for Cancer Therapy: A Novel Strategy in Drug Development
Jan Stenvang, Iben Kümler, Sune Boris Nygård, David Hersey Smith, Dorte Nielsen, Nils Brünner, and Jose Manuel Afonso Moreira
Design of Optimized Hypoxia-Activated Prodrugs Using Pharmacokinetic/Pharmacodynamic Modeling
Annika Bettina Foehrenbacher, Timothy W. Secomb, William R. Wilson, and Kevin O Hicks
Where is it and How Does it Get There – Intracellular Localization and Traffic of P-glycoprotein
Dong Fu
Small and Innovative Molecules as New Strategy to Revert MDR
Laura Zinzi, Elena Capparelli, Mariangela Cantore, Marialessandra Contino, Marcello Leopoldo, and Nicola Antonio Colabufo

Frontiers in Oncology, Section “Radiation Oncology”

Incident Learning and Failure-Mode-and-Effects-Analysis Guided Safety Initiatives in Radiation Medicine
Ajay Kapur, Petrina Zuvic, Gina Goode, Catherine Riehl, Sherin Joseph, Nilda Adair, Michael Interrante, Beatrice Bloom, Lucille Lee, Rajiv Sharma, Anurag Sharma, Jeffrey Antone, Adam Christopher Riegel, Lili Vijeh, Honglai Zhang, Yijian Cao, Carol Morgenstern, Elaine Montchal, Brett Cox, and Louis Potters
Quality Assurance for Clinical Trials
Geoffrey Stephen Ibbott, Annette Haworth, and David Scott Followill
Prevalence of ATM Sequence Variants in Northern Plains American Indian Cancer Patients
Daniel Grant Petereit
Yttrium-90 Radioembolization in Patients with Hepatocellular Carcinoma Who have Previously Received Sorafenib
Nitesh Rana, Andrew Wenhua Ju, Michael Bazylewicz, Bhaskar Kallakury, Aiwu Ruth He, Keith R Unger, and Justin S Lee
Internal Qualification and Credentialing of Radiation Oncology Physicists to Perform Patient Special Procedures
Michael D Mills
The Potential and Hurdles of Targeted Alpha Therapy – Clinical Trials and Beyond
Jorgen Elgqvist, Sofia Frost, Jean-Pierre Pouget, and Per Albertsson

Frontiers in Oncology, Section “Thoracic Oncology”

Anti-Apoptotic Signature in Thymic Squamous Cell Carcinomas – Functional Relevance of Anti-Apoptotic BIRC3 Expression in the Thymic Carcinoma Cell Line 1889c
Bei Huang, Djeda Belharazem, Li Li, Susanne Kneitz, Philipp Schnabel, Ralf Rieker, Daniel Körner, Winnfried Nix, Berthold Schalke, Hans Konrad Müller-Hermelink, German Ott, Andreas Rosenwald, Philipp Ströbel, and Alexander Marx
Radiotherapy for Thymic Carcinoma: Adjuvant, Inductive, and Definitive
Ritsuko Komaki and Daniel Gomez
Surgical Approaches for Stage IVA Thymic Epithelial Tumors
Mark Shapiro and Robert J Korst

Frontiers in Oncology, Section “Women's Cancer”

Current Status and Evolution of Preclinical Drug Development Models of Epithelial Ovarian Cancer
Panagiotis A Konstantinopoulos and Ursula A Matulonis
BRCA and Early Events in the Development of Serous Ovarian Cancer
Sophia HL George and Patricia Shaw
Connect with us on Facebook LinkedIn Google+ Vimeo Follow the latest articles of
Frontiers in Oncology
Twitter RSS
Frontiers in Oncology  |  EPFL Innovation Park, 1015 Lausanne, Switzerland  |  +41 21 510 17 11  |  info@frontiersin.org  |  www.frontiersin.org
Feel free to suggest your colleagues to stay in touch with our news and sign in to Frontiers Alerts.